These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 34286806)

  • 1. Association of polyunsaturated fatty acids with improved heart rate variability and cardiovascular events in patients with end-stage renal disease receiving maintenance dialysis: a systematic review and meta-analysis of randomized controlled trials.
    Chou CL; Chen JS; Kang YN; Chen YJ; Fang TC
    Food Funct; 2021 Sep; 12(17):8090-8099. PubMed ID: 34286806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: Systematic review and meta-analysis of randomized controlled trials.
    Saglimbene VM; Wong G; van Zwieten A; Palmer SC; Ruospo M; Natale P; Campbell K; Teixeira-Pinto A; Craig JC; Strippoli GFM
    Clin Nutr; 2020 Feb; 39(2):358-368. PubMed ID: 30905498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marine n-3 PUFA, heart rate variability and ventricular arrhythmias in patients on chronic dialysis: a cross-sectional study.
    Rantanen JM; Schmidt EB; Riahi S; Lundbye-Christensen S; Christensen JH
    Br J Nutr; 2018 Aug; 120(3):317-325. PubMed ID: 29779501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega-3 Polyunsaturated Fatty Acid Supplementation to Prevent Arteriovenous Fistula and Graft Failure: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Viecelli AK; Irish AB; Polkinghorne KR; Hawley CM; Johnson DW; Mori TA; Pascoe EM; Strippoli GFM; Lok CE; Palmer SC
    Am J Kidney Dis; 2018 Jul; 72(1):50-61. PubMed ID: 29395485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Marine
    Rantanen JM; Riahi S; Johansen MB; Schmidt EB; Christensen JH
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30227610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary interventions for multiple sclerosis.
    Farinotti M; Vacchi L; Simi S; Di Pietrantonj C; Brait L; Filippini G
    Cochrane Database Syst Rev; 2012 Dec; 12():CD004192. PubMed ID: 23235605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary Hypertension, Mortality, and Cardiovascular Disease in CKD and ESRD Patients: A Systematic Review and Meta-analysis.
    Tang M; Batty JA; Lin C; Fan X; Chan KE; Kalim S
    Am J Kidney Dis; 2018 Jul; 72(1):75-83. PubMed ID: 29429751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of polyunsaturated fatty acids for dry eye syndrome: a meta-analysis of randomized controlled trials.
    Zhu W; Wu Y; Li G; Wang J; Li X
    Nutr Rev; 2014 Oct; 72(10):662-71. PubMed ID: 25236365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease.
    Downie LE; Ng SM; Lindsley KB; Akpek EK
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011016. PubMed ID: 31847055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMG CoA reductase inhibitors (statins) for dialysis patients.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Nigwekar SU; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2013 Sep; 2013(9):CD004289. PubMed ID: 24022428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyunsaturated fatty acid supplementation in infancy for the prevention of allergy.
    Schindler T; Sinn JK; Osborn DA
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD010112. PubMed ID: 27788565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid therapy and cardiovascular disease in ESRD or advanced chronic kidney disease: a meta-analysis.
    Qin X; Huo Y; Langman CB; Hou F; Chen Y; Matossian D; Xu X; Wang X
    Clin J Am Soc Nephrol; 2011 Mar; 6(3):482-8. PubMed ID: 21088292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events and residual renal function in dialysis patients: a meta-analysis of randomised controlled trials.
    Liu Y; Ma X; Zheng J; Jia J; Yan T
    BMC Nephrol; 2017 Jun; 18(1):206. PubMed ID: 28666408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyunsaturated fatty acid supplementation for drug-resistant epilepsy.
    Sarmento Vasconcelos V; Macedo CR; de Souza Pedrosa A; Pereira Gomes Morais E; Porfírio GJ; Torloni MR
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011014. PubMed ID: 27536971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients.
    Ballinger AE; Palmer SC; Nistor I; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2014; 2014(12):CD006254. PubMed ID: 25490118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Marine
    Lilleberg HS; Cichosz SL; Svensson M; Christensen JH; Fleischer J; Eide I; Jenssen T
    Nutrients; 2019 Nov; 11(12):. PubMed ID: 31757095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance and therapeutic option of heart rate variability in chronic kidney disease.
    Zhang J; Wang N
    Int Urol Nephrol; 2014 Jan; 46(1):19-25. PubMed ID: 23539130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary interventions for adults with chronic kidney disease.
    Palmer SC; Maggo JK; Campbell KL; Craig JC; Johnson DW; Sutanto B; Ruospo M; Tong A; Strippoli GF
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011998. PubMed ID: 28434208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Icodextrin Versus Glucose Solutions for the Once-Daily Long Dwell in Peritoneal Dialysis: An Enriched Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Goossen K; Becker M; Marshall MR; Bühn S; Breuing J; Firanek CA; Hess S; Nariai H; Sloand JA; Yao Q; Chang TI; Chen J; Paniagua R; Takatori Y; Wada J; Pieper D
    Am J Kidney Dis; 2020 Jun; 75(6):830-846. PubMed ID: 32033860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.